Chong S. Lee
University of British Columbia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chong S. Lee.
Brain | 2009
Ramachandiran Nandhagopal; Lisa Kuramoto; Michael Schulzer; Edwin Mak; Jacquelyn J. Cragg; Chong S. Lee; J. McKenzie; Siobhan McCormick; Ali Samii; André R. Troiano; Thomas J. Ruth; Vesna Sossi; R. de la Fuente-Fernández; Donald B. Calne; A. J. Stoessl
Parkinsons disease is a heterogeneous disorder with multiple factors contributing to disease initiation and progression. Using serial, multi-tracer positron emission tomography imaging, we studied a cohort of 78 subjects with sporadic Parkinsons disease to understand the disease course better. Subjects were scanned with radiotracers of presynaptic dopaminergic integrity at baseline and again after 4 and 8 years of follow-up. Non-linear multivariate regression analyses, using random effects, of the form BP(ND)(t) or K(occ)(t) = a*e((-)(bt)(-d)(A) + c, where BP(ND) = tracer binding potential (nondispaceable), K(OCC) = tracer uptake constant a, b, c and d are regression parameters, t is the symptom duration and A is the age at onset, were utilized to model the longitudinal progression of radiotracer binding/uptake. We found that the initial tracer binding/uptake was significantly different in anterior versus posterior striatal subregions, indicating that the degree of denervation at disease onset was different between regions. However, the relative rate of decline in tracer binding/uptake was similar between the striatal subregions. While an antero-posterior gradient of severity was maintained for dopamine synthesis, storage and reuptake, the asymmetry between the more and less affected striatum became less prominent over the disease course. Our study suggests that the mechanisms underlying Parkinsons disease initiation and progression are probably different. Whereas factors responsible for disease initiation affect striatal subregions differently, those factors contributing to disease progression affect all striatal subregions to a similar degree and may therefore reflect non-specific mechanisms such as oxidative stress, inflammation or excitotoxicity.
Annals of Neurology | 2011
Raúl de la Fuente-Fernández; Michael Schulzer; Lisa Kuramoto; Jacquelyn J. Cragg; Nandhagopal Ramachandiran; Wing Lok Au; Edwin Mak; Jess McKenzie; Siobhan McCormick; Vesna Sossi; Thomas J. Ruth; Chong S. Lee; Donald B. Calne; A. Jon Stoessl
To investigate in vivo the impact of age on nigrostriatal dopamine dysfunction in Parkinsons disease (PD).
Neurology | 1995
Chong S. Lee; Michael Schulzer; Edwin Mak; John P. Hammerstad; Susan Calne; Donald B. Calne
Article abstract-We investigated the asymmetry of focal deficits of bradykinesia in a cross-sectional study of 198 patients with idiopathic parkinsonism. We have analyzed the difference in Unified Parkinsons Disease Rating Scale (UPDRS) scores between the more and less affected sides in these patients, whose duration of symptoms ranged from 1 to 15 years. There was no significant change in the asymmetry or focality over this period; the deficit for each side progressed faster initially and then approached the normal age-related linear rate of decline. Previous studies indicate that there is an inverse linear relation between the UPDRS bradykinesia score and the nigral dopaminergic cell count. We infer that the rate of death of nigral dopaminergic neurons is predetermined from the time of onset of pathogenesis. The simplest explanation is that a causal event kills some cells and damages others so that they undergo premature death. This sequence of changes could be implemented through environmental (toxic or viral) damage to the genome. Several diverse sources of evidence support this concept. NEUROLOGY 1995;45: 435-439
Annals of Neurology | 1992
Donald B. Calne; Barry J. Snow; Chong S. Lee
Brain | 2005
John R. Adams; Hinke van Netten; Michael Schulzer; Edwin Mak; Jessamyn McKenzie; Audrey Strongosky; Vesna Sossi; Thomas J. Ruth; Chong S. Lee; Matthew J. Farrer; Thomas Gasser; Ryan J. Uitti; Donald B. Calne; Zbigniew K. Wszolek; A. Jon Stoessl
Annals of Neurology | 1994
François J.G. Vingerhoets; Barry J. Snow; Chong S. Lee; Michael Schulzer; Edwin Mak; Donald B. Calne
Brain | 1994
Chong S. Lee; Michael Schulzer; Edwin Mak; Barry J. Snow; Joseph K.C. Tsui; Susan Calne; John P. Hammerstad; Donald B. Calne
Annals of Neurology | 1994
Thomas Gasser; Zbigniew K. Wszolek; James A. Trofatter; Laurie J. Ozelius; Ryan J. Uitti; Chong S. Lee; James F. Gusella; Ronald F. Pfeiffer; Donald B. Calne; Xandra O. Breakefield
Synapse | 2003
Raúl de la Fuente-Fernández; Sarah Furtado; Mark Guttman; Yoshiaki Furukawa; Chong S. Lee; Donald B. Calne; Thomas J. Ruth; A. Jon Stoessl
Synapse | 2003
Raúl de la Fuente-Fernández; Andrew V.S. Lim; Vesna Sossi; Michael J. Adam; Thomas J. Ruth; Donald B. Calne; A. Jon Stoessl; Chong S. Lee